0001209191-17-038864.txt : 20170609
0001209191-17-038864.hdr.sgml : 20170609
20170609160918
ACCESSION NUMBER: 0001209191-17-038864
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170608
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cagle Gerald D.
CENTRAL INDEX KEY: 0001589991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 17903024
MAIL ADDRESS:
STREET 1: 135 U.S. HIGHWAY 206
STREET 2: SUITE 15
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-08
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001589991
Cagle Gerald D.
C/O AERIE PHARMACEUTICALS, INC.
2030 MAIN STREET, SUITE 1500
IRVINE
CA
92614
1
0
0
0
Common Stock
2017-06-08
4
A
0
1150
0.00
A
14050
D
Stock Option (right to buy)
52.85
2017-06-08
4
A
0
10000
0.00
A
2027-06-08
Common Stock
10000
10000
D
Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 8, 2018.
Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 8, 2017.
/s/ Richard J. Rubino, Attorney-in-Fact for Gerald D. Cagle
2017-06-09